Balyasny Asset Management
OXFD

Balyasny Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Balyasny Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-15,748
Closed -$203K – 2186
2018
Q2 		$203K Sell
15,748
-700
-4% -$9.46K ﹤0.01% 1639
2018
Q1 		$205K Buy
+16,448
New +$200K ﹤0.01% 1757

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Balyasny Asset Management's OXFD Position: Q3 2018 in Review

Balyasny Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2018, closing a stake of 15,748 shares — an estimated $203K sold.

Balyasny Asset Management first reported a position in OXFD in Q1 2018 and held it in 2 quarters. The position peaked at $205K in Q1 2018. 83 funds tracked by Wall St. Rank hold OXFD as of Q3 2018.

  • Balyasny Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 15,748 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2018, an estimated $203K.
  • Balyasny Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2018 and held it in 2 quarters.
  • Balyasny Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $205K in Q1 2018.
  • 83 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.